Back

Characterization and clinical significance of hemolysis after pulsed-field ablation for atrial fibrillation: insights from a multicentric analysis

7 April 2024 (08:30 - 15:00)
Organised by: Logo
Congress Presentation Part of: Arrhythmias 11: atrial fibrillation Catheter Ablation of Arrhythmias EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Miruna-Andreea Popa

German Heart Centre Munich, Munich (Germany)

7 More presentations in this session

Presentation thumbnail
Focal pulsed field ablation in complex cases of atrial tachycardia - feasibility, outcome and safety of a novel technology
Doctor F. Bahlke (Munich, DE)
Abstract Slides Video
Presentation thumbnail
Comparison of two DCCV algorithms - rational versus maximum fixed energy (PROTOCOLENERGY trial)
Doctor L. Rucki (Trinec, CZ)
Abstract Slides Video
Presentation thumbnail
One-year freedom from arrhythmia following radiofrequency ablation using proactive oesophageal cooling
Professor M. Gallagher (London, GB)
Abstract Slides Video
Presentation thumbnail
Impact of continuous positive airway pressure for severe sleep apnea on very late recurrence in patients receiving catheter ablation of atrial fibrillation
Doctor N. Tanaka (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
Localization of ganglionated plexi by high density mapping: an atropine-response analysis
Doctor A. Giomi (Florence, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Arrhythmias 11: atrial fibrillation

The Event

Event poster

EHRA 2024

7 April - 9 April 2024
You may be interested in
thumbnail
Congress Presentation
Comparison of hemolysis induced by different pulsed-field ablation systems
thumbnail
Congress Presentation
Periprocedural assessment of intravascular hemolysis and renal function during atrial fibrillation ablation using pulse field and cryoablation - preliminary results
thumbnail
Congress Presentation
Haemolysis and acute tubular injury after pulsed field ablation compared to radiofrequency: An observational study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources